Patheon France S.A.S is a finished-dose manufacturer based in United Arab Emirates. It appears in 23 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with JFDA (JO), DIGEMAPS (DO) and NPRA (MY). Its GMP standing is certified by MFDS (Korea), US FDA and NAFDAC (NG). Its most recent recorded inspection, by US FDA, closed on 29 September 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bourgoin-Jallieu, United Arab Emirates | Not on file |
| Ontario, United Arab Emirates | Not on file |
| Ferentino, United Arab Emirates | Not on file |
| France, France | 3004468553 |
| Bourgoin-Jallieu, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Neostigmine Metilsulfate | SFDA (Saudi Arabia) | 1 |
| Ponesimod | SFDA (Saudi Arabia) | 1 |
| Pyridostigmine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| JFDA (JO) | 9 | None |
| DIGEMAPS (DO) | 4 | None |
| NPRA (MY) | 2 | None |
| EDE (AE) | 2 | None |
| ARCSA (EC) | 2 | None |
| UZPHARM (UZ) | 2 | None |
| MFDS (Korea) | None | 12 |
| US FDA | None | 1 |
| NAFDAC (NG) | None | 1 |
Choose your molecules and target markets. Patheon France S.A.S comes back tiered against every other supplier able to file there.
Start for free